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Engagement of the Fas receptor (CD95) initiates multiple signaling pathways that lead to 
apoptosis, such as the formation of death-inducing signaling complex (DISC), activation of 
caspase cascades, and the generation of the lipid messenger, ceramide. Sphingomyelin (SM) 
is a major component of lipid rafts, which are specialized structures that enhance the 
efficiency of membrane receptor signaling and are a main source of ceramide. However, the 
functions of SM in Fas-mediated apoptosis have yet to be clearly defined, as the responsible 
genes have not been identified. After cloning a gene responsible for SM synthesis, 
 
SMS1
 
, we 
established SM synthase–defective WR19L cells transfected with the human Fas gene 
(WR/Fas-SM(
 
 
 
)), and cells that have been functionally restored by transfection with 
 
SMS1 
 
(WR/Fas-SMS1). We show that expression of membrane SM enhances Fas-mediated 
apoptosis through increasing DISC formation, activation of caspases, efficient translocation 
of Fas into lipid rafts, and subsequent Fas clustering. Furthermore, WR/Fas-SMS1 cells, but 
not WR/Fas-SM(
 
 
 
) cells, showed a considerable increase in ceramide generation within lipid 
rafts upon Fas stimulation. These data suggest that a membrane SM is important for Fas 
clustering through aggregation of lipid rafts, leading to Fas-mediated apoptosis.
 
Fas, also known as CD95, is a death domain–
containing member of the TNFR super family
(1). Currently, two distinct pathways that require
different initiator caspases (caspase-8, -9, and -10)
but converge at activation of executor caspases
(caspase-3, -6, and -7) are proposed in Fas-
mediated apoptosis signaling (2, 3). In type I
cell apoptosis (mitochondrion independent),
engagement by Fas ligand (FasL), or anti-Fas
antibody (CH11), leads to receptor trimerization
and recruitment of the cytoplasmic adaptor
protein, Fas-associated death domain (FADD),
and procaspase-8 and -10, thus forming a death-
inducing signaling complex (DISC). On the
other hand, in type II cell apoptosis (mito-
chondrion dependent), minimal caspase-8 can
cleave the Bcl-2 family member Bid. The
truncated Bid translocates to mitochondria,
where it perturbs the mitochondrial membrane
potential (
 
  
 
m) and facilitates the formation of
mitochondrial permeability transition pores, re-
sulting in the release of cytochrome 
 
c
 
 (4).
Aggregation and clustering of cell surface
receptors on binding to their specific ligands
has been reported for a variety of receptors, in-
cluding the TCR–CD3 complex, B cell re-
ceptor, TNFR, epithelial-derived growth factor
receptor, CD2, CD44, CD11a/CD18, and Fas,
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and is facilitated by localization of receptor and proximal
signaling components within cholesterol, glycosphingolip-
ids, and sphingomyelin (SM)-rich membrane microdomains,
known as lipid rafts (5–9). Recently, there is accumulating
evidence that rafts are involved in Fas-induced apoptosis
through the translocation and clustering of Fas into rafts on
stimulation (7, 10, 11). Studies have reported that Fas ligation
triggers translocation of the acid sphingomyelinase (aSMase)
from an intracellular compartment onto the cell surface,
where it hydrolyzes SM to ceramide, and that accumulation
of ceramide contributes to transforming small rafts into larger
signaling platforms that trap and cluster Fas (7, 10). Rafts have
been detected using choleratoxin B (CTx), which binds to
ganglioside GM1 colocalized in rafts, and the role of rafts has
been evaluated by the disruption of rafts using the cholesterol-
chelating reagent methyl-
 
 
 
-cyclodextrin. However, there has
been no direct evidence that membrane SM, a major raft
component, is involved in raft functions or Fas-mediated
apoptosis. Very recently, we and others have succeeded in
cloning the human cDNA for SM synthase (
 
SMS1
 
; references
12 and 13). Using SM synthesis–deficient cells, and cells in
which function has been restored by transfection with the
novel 
 
SMS1
 
 gene, we demonstrated that expression of mem-
brane SM enhanced Fas-mediated apoptosis through efficient
clustering of Fas itself with a concomitant increase in DISC
formation, the activation of caspases, and the loss of 
 
  
 
m.
 
RESULTS
Characterization of SM-deficient and functionally restored 
cells by transfection with the SM synthase gene
 
Lysenin is an SM-directed cytolysin purified from the earth-
worm (14), which binds to membrane SM and induces pore
formation in the plasma membrane and subsequent cell
death (14). During investigation of the sphingolipid metabo-
lism in SM synthase–defective WR19L mouse lymphoid
cells transfected with the human 
 
Fas 
 
gene (WR19L/Fas; ref-
erence 15), we established membrane sphigomyelin-defi-
cient cells, WR/Fas-SM(
 
 
 
), which were resistant to lyse-
nin-mediated cell lysis. Recently, we established a functional
revertant cell line, designated WR/Fas-SMS1 cells, by trans-
fection of 
 
SMS1
 
 (12). WR/Fas-SMS1 cells exhibited re-
stored SM synthesis assayed by radiolabeling of cellular lipids
with [
 
14
 
C]serine (Fig. 1 A) and recovered sensitivity against
lysenin-mediated cytolysis (not depicted; reference 12).
Recently, Yamaji-Hasegawa et al. produced a mutant ly-
senin, which specifically binds to SM without induction of
cell death (16). Using the mutant lysenin conjugated with
maltose-binding protein (MBP), we examined SM expres-
sion on the plasma membrane of WR/Fas-SM(
 
 
 
) and WR/
Fas-SMS1 cells by confocal microscopy. Expression of SM
detected by lysenin–MBP plus FITC-labeled anti-MBP anti-
body was positive in WR/Fas-SMS1 but not in WR/Fas-
SM(
 
 
 
) cells (Fig. 1 B). Membrane expression of ganglioside
GM1 detected by FITC-labeled CTx was observed on both
cells (not depicted; reference 12).
We confirmed the accumulation of SM on the surface of
WR/Fas-SM(
 
 
 
) and WR/Fas-SMS1 cells by FACS analysis.
Binding of lysenin–MBP was positive in WR/Fas-SMS1 cells
but not in WR/Fas-SM(
 
 
 
) cells. We also examined the ex-
pression of other lipid components of the plasma membrane,
such as ganglioside GM1 and cholesterol, as well as the expres-
sion of human Fas. Binding of CTx, which binds the oligosac-
charide portion of ganglioside GM1, considered to be a maker
of lipid rafts, and binding of fluorescein ester of polyethylene
glycol-derivatized cholesterol (fPEG-cholesterol; reference 17),
which specifically binds membrane cholesterol, as well as ex-
pression of Fas, was detected equally on both cells (Fig. 1 C).
 
Fas-mediated apoptosis and loss of 
 
  
 
m in WR/Fas-SM(
 
 
 
) 
and WR/Fas-SMS1 cells
 
Although Itoh et al. have reported that cross-linking of hu-
man Fas on WR19L/Fas cells promotes type I cell apoptosis
(15), we found that WR/Fas-SM(
 
 
 
) cells are resistant to Fas-
mediated apoptosis. Therefore, we used WR/Fas-SM(
 
 
 
) and
WR/Fas-SMS1 cells to determine whether membrane SM
Figure 1. Characterization of WR/Fas-SM( ) and WR/Fas-SMS1 
cells. (A) SM synthase activity of WR/Fas-SM( ) (lane 1) and WR/Fas-
SMS1 (lane 2) cells. The cellular lipids were labeled with [14C]serine, extracted 
by the Bligh and Dyer method (reference 53), and assessed by TLC. PE, 
phosphatidylethanolamine; PS, phosphatidylserine. (B) Analysis of membrane 
SM expression by confocal microscopy. Cells were stained with lysenin-MBP, 
and FITC-conjugated anti–mouse IgG mAb, then examined by laser scan 
confocal microscopy. (C) FACS analysis of membrane sphingolipids. To detect 
membrane SM, cells were stained with lysenin-MBP (Lysenin), CH11, and 
FITC-conjugated anti–mouse IgG mAb. Surface expression of ganglioside 
GM1, cholesterol, and human Fas were analyzed using FITC-conjugated 
CTx, cholesterol-PEG (cholesterol), or anti-Fas mAB (h-Fas), respectively. 
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plays an important role in Fas-mediated apoptosis. Because
high antibody concentrations might cause Fas clustering (7),
we determined the optimal conditions for Fas-mediated
apoptosis by analyzing the effect of concentration of agonistic
CH11 (mouse IgM) and the time course of response of these
cells. WR/Fas-SMS1 cells underwent stronger apoptosis at 50
ng/ml CH11 than WR/Fas-SM(
 
 
 
) cells, exhibiting 31 and
9.9% apoptosis, respectively (Fig. 2 A). Although apoptosis
was increased in a dose-dependent manner in both cells, high
concentrations of CH11 (up to 500 ng/ml) induced only
24.3% apoptosis in WR/SMS(
 
 
 
) cells (Fig. 2 B). In subse-
quent experiments, cells were treated with 50 ng/ml of CH11
as the optimum condition for apoptosis. Next, cells were
stimulated with 50 ng/ml CH11 for the indicated time, and
WR/Fas-SMS1 cells showed stronger apoptosis compared
with WR/Fas-SM(
 
 
 
) cells at both 3 and 6 h (Fig. 2 C).
 
  
 
m during apoptosis is likely to contribute to the death
of the cell through the loss of mitochondrial function before
DNA fragmentation in both type I and II cell apoptosis. As
shown in Fig. 2 D, the treatment of WR/Fas-SMS1 cells
with CH11 dramatically induced a loss of 
 
  
 
m as deter-
mined by staining with DiOC
 
6
 
(3), a dye taken up by mito-
chondria, with similar time kinetics as Fas-mediated apopto-
sis. However, A majority of WR/Fas-SM(
 
 
 
) cells exhibited
a normal 
 
  
 
m through the assay (Fig. 2 D). The time kinet-
ics of loss of 
 
  
 
m were comparable to those of apoptosis.
Next, we examined whether Fas-mediated apoptosis of
WR/Fas-SM(
 
 
 
) and WR/Fas-SMS1 cells depends on cas-
pase activation. Cells were stimulated with 50 ng/ml CH11
for 6 h in the presence of the specific caspase-3 inhibitor
(Ac-DEVD-CHO) or the specific caspase-8 inhibitor (Ac-
IETD-CHO). As shown in Fig. 2 E, 100 
 
 
 
M of each inhib-
itor completely suppressed Fas-mediated apoptosis of WR/
Fas-SMS1 cells.
 
Fas-mediated caspase-3 activation of WR/Fas-SM(
 
 
 
) 
and WR/Fas-SMS1 cells
 
Cells were stimulated with 50 ng/ml CH11 for the indicated
time (Fig. 3 A) and at the indicated concentration for 30 min
(Fig. 3 B). Western blot analysis using a caspase-3–specific
antibody revealed that the active fragments (p17) of cas-
pase-3 cleaved from 32-kD pro–caspase-3 was expressed at a
Figure 2. Fas-mediated apoptosis in WR/Fas-SM( ) and WR/Fas-
SMS1 cells. (A and B) Dose dependency of Fas-mediated apoptosis. Cells 
were incubated for 3 h with the indicated concentration of CH11. After 
incubation, cells were harvested and analyzed by flow cytometry for DNA 
fragmentation using nuclear staining with PI. The numbers in each box 
represent the percentages of apoptotic cells. (C) Time kinetics of Fas-mediated 
apoptosis. Cells were incubated with 50 ng/ml of CH11 for the indicated 
time, and apoptosis was analyzed by flow cytometry using PI. Error bars 
represent SEM. (D) Time–kinetics of loss of   m in apoptotic cells. Cells 
were incubated with 50 ng/ml of CH11 for the indicated time.   m was 
determined by intracellular staining with DiOC6(3) and flow cytometry. 
(E) Inhibition of Fas-mediated apoptosis by caspase inhibitors. Cells were 
stimulated with 50 ng/ml of CH11 for 6 h in the presence of the indicated 
amounts of Ac-DEVD-CHO or Ac-IETD-CHO. After incubation, apoptosis 
was analyzed by flow cytometry using PI. 
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higher level in WR/Fas-SMS1 cells compared with WR/
Fas-SM(
 
 
 
) cells in time-dependent (Fig. 3 A) and concen-
tration of Fas antibody–dependent manners (Fig. 3 B). As
shown in Fig. 3 C, colorimetric assay revealed that cytoplas-
mic caspase-3 activity of WR/Fas-SMS1 cells increased
more than twofold over baseline by Fas cross-linking. How-
ever, caspase-3 activity of WR/Fas-SM(
 
 
 
) cells remained at
baseline for the entire 6 h.
 
Fas-mediated DISC formation and caspase-8 activation in 
WR/Fas-SM(
 
 
 
) and WR/Fas-SMS1 cells
 
According to the current model of type I apoptosis, binding
of either the FasL or an agonistic antibody induces aggrega-
tion of Fas followed by a conformational change in its cyto-
plasmic domain that results in formation of the DISC (2, 3,
18). Therefore, we examined DISC formation in WR/Fas-
SM(
 
 
 
) and WR/Fas-SMS1 cells. Cells were stimulated
with 50 ng/ml CH11 for the indicated time (Fig. 4 A) and
at the indicated concentration (Fig. 4 B) for 30 min. After
lysis, Fas was immunoprecipitated with anti–mouse IgM an-
tibody, and precipitated proteins were examined by immu-
noblotting with anti-FADD or anti–caspase-8 antibody. The
results of the time course study revealed that FADD associ-
ated with Fas within 5 min in both cells. However, the asso-
ciation of FADD and Fas in WR/Fas-SMS1 cells was stron-
ger and sooner (with the maximum association at 5 min)
than in WR/Fas-SM(
 
 
 
) cells, in which the association
gradually increased over the 30-min period. Caspase-8 ap-
peared within the DISC in WR/Fas-SMS1 cells after 5 min
of stimulation and reached maximum levels at 15 min.
However, caspase-8 within DISC in WR/Fas-SM(
 
 
 
) cells
was barely detectable throughout the assay (Fig. 4 A). The
results of a dose-dependent experiment revealed that associ-
ation of FADD and caspase-8 with Fas in WR/Fas-SMS1
cells appeared much stronger than in WR/Fas-SM(
 
 
 
) cells
at any concentration of antibody (Fig. 4 B). Although
FADD was detected in the DISC after stimulation with 5
ng/ml CH11 in both cell types, caspase-8 appeared in the
DISC at a relatively high concentration of CH11; i.e., 25
ng/ml for WR/Fas-SMS1 and 50 ng/ml for WR/Fas-
SM(
 
 
 
) cells, respectively (Fig. 4 B).
Figure 3. Fas-mediated caspase-3 activation in WR/Fas-SM( ) 
and WR/Fas-SMS1 cells. Time kinetics (A) and dose dependency (B) of 
caspase-3 activation by Western blot analysis. Cells were stimulated with 
50 ng/ml CH11 for the indicated time (A), or stimulated with the indicated 
concentration of CH11 for 15 min (B). Total cell lysates were analyzed by 
Western blot using mouse mAb to caspase-3. The arrows indicate the 
bands corresponding to 32 kD for procaspase-3 (pro) and 17 kD for the 
active caspase (active). (C) Cells were stimulated with 50 ng/ml CH11 for 
the indicated time, and caspase-3 activities were measured in extracts of 
cell lysates using colorimetric assay kits. Each experiment was done in 
triplicate. Data are representative of five independent experiments. Error 
bars represent SEM.
Figure 4. Fas-mediated DISC formation and caspase-8 activation 
in WR/Fas-SM( ) and WR/Fas-SMS1 cells. Time kinetics (A) and dose 
dependency (B) of Fas-mediated DISC formation. 2   107 cells were stimu-
lated with 50 ng/ml CH11 for the indicated time (A) or stimulated for 15 min 
with the indicated concentration of CH11 (B). After stimulation, Fas was 
immunoprecipitated with anti–mouse IgM antibody from Brij 97 lysates. 
Immunoprecipitates were subjected to 12% SDS-PAGE and immunoblotted 
with anti-Fas death domain (3D5), anti-FADD, and anti–caspase-8 mAb. 
Data are representative of five independent experiments. (C) Fas-mediated 
activation of caspase-8. Cells were stimulated with 50 ng/ml CH11 for the 
indicated time, and caspase-8 activities were measured in extracts of cell 
lysates using colorimetric assay kits. Each experiment was done in tripli-
cate. Data are representative of five independent experiments. Error bars 
represent SEM. 
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We also examined the cytoplasmic caspase-8 activity in
WR/Fas-SM(
 
 
 
) and WR/Fas-SMS1 cells after Fas cross-
linking by colorimetric assay. Interestingly, caspase-8 activi-
ties in WR/Fas-SMS1 cells exhibited a biphasic peak after
stimulation: the first small peak appeared within 1 h; and the
second high peak, after 2 h. However, caspase-8 activity in
WR/Fas-SM(
 
 
 
) cells remained at baseline for 3 h, with
slight increase at 4 h (Fig. 4 C).
 
Fas aggregation and capping in WR/Fas-SM(
 
 
 
) 
and WR/Fas-SMS1 cells
 
It has been reported that Fas, as well as TNFR, assemble into
trimers in the absence of ligands (19, 20). Although Fas tri-
mers do not trigger apoptosis in the resting condition, cluster-
ing of these trimers is crucial for Fas-mediated apoptosis (18,
21). CH11 causes the formation of Fas multimers, thereby
inducing complete cellular activation leading to capping.
Kamitani et al. reported that cross-linking of Fas on the cell
surface by CH11 resulted in the formation of high molecular
mass Fas aggregates, which were stable in 2% SDS and 5%
 
 
 
-mercaptoethanol (22). As shown in Fig. 5, stimulation with
CH11 induced the formation of SDS- and 2-ME–stable,
high molecular aggregates (
 
 
 
200 kD) of Fas in both cells, as
reported by others (22, 23). Fas aggregates appeared more
strongly in WR/Fas-SMS1 cells compared with WR/Fas-
SM(
 
 
 
) cells in time-dependent (Fig. 5 A) and CH11 dose–
dependent (Fig. 5 B) fashions.
We used confocal microscopy to examine Fas capping
on the plasma membrane of WR/Fas-SM(
 
 
 
) and WR/Fas-
SMS1 cells after treatment with 50 ng/ml CH11
 
 
 
as described
in Materials and methods. In unstimulated cells, Fas was
diffusely distributed across the surface on both WR/Fas-
SM(
 
 
 
) and WR/Fas-SMS1 cells (Fig. 5 C, 0 min). Cross-
linking of Fas with antibody induced small patches of Fas
along the plasma membrane, which appeared to fuse to
 
 
 
large
clusters/capping in WR/Fas-SMS1 cells (Fig. 5 C, 30 min).
The frequency of Fas capping on WR/Fas-SMS1 cells was
significantly greater than that of WR/Fas-SM(
 
 
 
) cells at
each time point (P 
 
 
 
 0.01; Fig. 5 D).
 
Fas distribution in lipid rafts of WR/Fas-SM(
 
 
 
) 
and WR/Fas-SMS1 cells
 
Recent studies have shown that rafts play an important role
in signal transduction pathways, including apoptosis and, in
particular, through the organization of surface receptors, sig-
naling enzymes, and adaptor molecules into rafts (5, 24).
Muppidi et al. have reported that translocation of Fas into
lipid rafts increased sensitivity to Fas-mediated apoptosis
(25). To determine Fas distribution of WR/Fas-SM(
 
 
 
) and
WR/Fas-SMS1 cells, rafts were isolated using equilibrium
Figure 5. Fas clustering and capping in WR/Fas-SM( ) and WR/
Fas-SMS1 cells. Time kinetics (A) and dose dependency (B) of Fas multimer 
formation. 4   107 cells were stimulated with 50 ng/ml CH11 for the indi-
cated time (A), or stimulated for 10 min with the indicated concentration 
of CH11 (B). After stimulation, cell pellets were snap frozen and treated at 
45 C for 1 h in 300  l of a 1% NP-40–treating solution. DNA in the samples 
was sheared with a 25-gauge needle, and solubilized samples were loaded 
on 12% SDS-PAGE. Fas multimers were detected with antibody to the 
intracellular death domain of human Fas (3D5). Data are representative of 
more than three independent experiments. (C) Activation-induced capping 
of Fas. Cells were stained for 20 min with 50 ng/ml CH11 at 4 C. Afterwards, 
capping was induced by warming cells to 37 C for 30 min in a water bath 
with mild agitation. Cells were harvested at the indicated times and fixed 
with 4% paraformaldehyde for 20 min at 22 C. Fixed cells were washed 
twice and mounted in FITC-conjugated secondary antibody. Fluorescence 
was detected using a confocal microscope equipped with a SPOT digital 
camera. The data are representative of more than five experiments. Arrow-
heads indicate Fas capping. (D) Time kinetics of activation-induced Fas 
capping. Capping was induced for the indicated time, and cells with Fas 
clustering were counted by two independent observers. Percentages of 
capping were calculated in 150–200 total cells. These results are the mean 
of three independent experiments. Error bars represent SEM. *, P   0.01.SPHINGOMYELIN/CERAMIDE RAFTS IN APOPTOSIS | Miyaji et al. 254
sucrose density gradients. The position of the membrane
rafts in the sucrose gradient was determined by the presence
of lck, a well-established raft-associated molecule. As shown
in Fig. 6, lck was enriched in the upper part of the sucrose
gradient (fractions 4 and 5), with a secondary localization at
the bottom of the gradient in which a cytoskeletal protein,
tublin, was localized (fractions 10–12), indicating a separa-
tion of the lipid rafts (fractions 4 and 5) from the Triton
X-100–soluble membrane. Fas was detected in raft fractions
of WR/Fas-SM( ) and WR/Fas-SMS1 cells before stimu-
lation (Fig. 6 A, a and b). Although a substantial shift of Fas
into raft fractions was observed in both cells after stimula-
tion, amounts of Fas in raft fractions were greater in WR/
Fas-SMS1 than in WR/Fas-SM( ) cells (Fig. 6 A, a and c
vs. Fig. 6 A, b and d). The mean of three independent ex-
periments revealed that Fas redistribution in raft fractions
was significantly greater in WR/Fas-SMS1 cells than in
those of WR/Fas-SM( ) cells after stimulation (P   0.01;
Fig. 6, B and C).
Ceramide generation in lipid rafts of WR/Fas-SM( ) 
and WR/Fas-SMS1 cells
Ceramide modulates the activity of a large number of pro-
teins, and a role in apoptosis induction has been proposed
(26–28). However, the signals that activate the enzyme re-
sponsible for ceramide production are not well defined, and
the actual contribution of ceramide to the apoptotic response
remains poorly understood. It has been reported that cer-
amide formation is associated with the execution phase of
apoptosis as a consequence of processes downstream of the
activation of caspases (29, 30). Consistent with this, we ob-
served delayed generation of cytosolic ceramide in WR/Fas-
SMS1 compared with WR/Fas-SM( ) cells after a 2-h Fas
stimulation (unpublished data). However, stress-induced SM
hydrolysis occurs rapidly, suggesting that the early event is lo-
cated in close proximity to the plasma membrane. Recently,
it has been reported that aSMase translocates into rafts within
minutes after cell stimulation and catalyzes the formation of
ceramide from SM (11, 31, 32). Therefore, we analyzed
membrane ceramide within lipid rafts in WR/Fas-SM( )
and WR/Fas-SMS1 cells. Although WR/Fas-SM( ) cells,
because of a lack of SM synthase, contain more ceramide
than WR/Fas-SMS1 cells, both cells showed a similar distri-
bution of ceramide among fractions (Fig. 7 A). Thus, in both
cell types, 70% of ceramide is located in raft fractions with
 40% in fraction 4 (Fig. 7 A, bottom). Because membrane
SM is one of the major sources of ceramide generation, we
next examined Fas-stimulated ceramide generation in raft
fractions of WR/Fas-SM( ) and WR/Fas-SMS1 cells. After
5 min of Fas stimulation, cells were lysed, and rafts were iso-
lated using equilibrium sucrose density gradients. Analysis of
ceramide in the raft fraction revealed that Fas cross-linking
increased ceramide content by 50% in WR/Fas-SMS1 cells
(from 2,955 to 4,386 pmol/106 cells), but marginally de-
creased ceramide in WR/Fas-SM( ) cells (from 5,960 to
5,651 pmol/106 cells; Fig. 7 B). The mean of three indepen-
dent experiments revealed that ceramide contents of raft frac-
tions in WR/Fas-SMS1 cells were significantly greater than
those of WR/Fas-SM( ) cells (P   0.01; Fig. 7 C).
Effects of exogenous ceramide on Fas-mediated apoptosis in 
WR/Fas-SM( ) and WR/Fas-SMS1 cells
We and others have shown that ceramide is a proapoptotic
lipid mediator because diverse mechanisms of cell stress, in-
cluding CH11 cross-linking, TNF-  treatment, irradiation,
heat shock, and anticancer drugs, increases intracellular cer-
amide during the execution phase of apoptosis (27, 28, 31,
33–37). It has been reported that the addition of natural or
Figure 6. Distribution of Fas into lipid rafts of WR/Fas-SM( ) and 
WR/Fas-SMS1 cells. (A) 108 cells were left unstimulated (a and b) or 
were stimulated with CH11 for 30 min (c and d), and Triton X-100 lysates 
were subjected to sucrose density gradient fractionation. Fractions were 
run on 15% SDS-PAGE and immunoblotted with antibodies against lck 
(a marker for the raft fractions), tublin (a marker for the nonraft fractions), 
and Fas (3D5). The blots shown are representative of four independent 
experiments. (B) Redistribution of Fas into lipid rafts on stimulation. Raft 
fractions (fraction 4) were run on 15% SDS-PAGE and immunoblotted 
with antibodies against lck and Fas. (C) Quantification of Fas contents in 
lipid rafts was performed densitometrically and normalized to the amount 
of lck. Data are expressed as the mean   SEM for relative increase of three 
independent experiments. *, P   0.01.JEM VOL. 202, July 18, 2005 255
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C16-ceramide, which by themselves did not induce apopto-
sis, enabled soluble FasL to cap and completely restore the
apoptosis in aSMase /  hepatocytes (10, 11, 38). Therefore,
we examined the effects of exogenous natural or C16-cer-
amide on Fas-mediated apoptosis and the formation of Fas
multimers in WR/Fas-SM( ) and WR/Fas-SMS1 cells.
Cells were pretreated with the indicated concentration of nat-
ural or C16-ceramide for 1 h. After washing, cells were stim-
ulated with 50 ng/ml of agonist CH11 for 6 h before assaying
for apoptosis, or 30 min before assessing Fas multimer forma-
tion. Although natural and C16-ceramide did not induce
apoptosis by themselves, both ceramides enhanced Fas-
induced apoptosis. However, high concentrations of ceramides,
even at 5  M, could not restore apoptosis of WR/Fas-
SM( ) cells to the levels of WR/Fas-SMS1 cells (Fig. 8, A
and B). We also examined the effects of natural  or C16-cer-
amide on Fas multimer formation and found that pretreat-
ment of cells with 5  M natural  or C16-ceramides did not
enhance Fas multimer formation in WR/Fas-SM( ) and
WR/Fas-SMS1 cells (unpublished data).
DISCUSSION
Currently, two distinct pathways are proposed in Fas-medi-
ated apoptosis signaling; i.e., type I and type II apoptosis. The
Figure 7. Ceramide generation in lipid rafts of WR/Fas-SM( ) and 
WR/Fas-SMS1 cells. (A) Ceramide contents in membrane fractions of 
sucrose density gradient fractionation. 108 cells were lysed in Triton X-100 
buffer and subjected to sucrose density gradient fractionation. Lipids of 
each fraction were extracted by the method of Bligh and Dyer (reference 53), 
and ceramide content was measured by the diacylglycerol kinase assay. After 
separation of ceramide-1-phosphates by TLC, radioactivity was visualized and 
estimated. The results are representative of three independent experiments 
and expressed as the percentage of total PSL arbitrary units. (B) Fas-mediated 
ceramide generation in lipid rafts. 108 cells were left unstimulated or were 
stimulated with CH11 for 5 min and Triton X-100 lysates were subjected to 
sucrose density gradient fractionation. Lipids of raft fraction (fraction 4) 
were extracted by the method of Bligh and Dyer, and ceramide generation 
was measured by the diacylglycerol kinase assay. Radioactivity was visualized 
and estimated. The results are representative of three independent experi-
ments. (C) The mean of three independent experiments revealed that ceramide 
contents of lipid rafts in WR/Fas-SMS1 cells were significantly greater than 
those of WR/Fas-SM( ) cells. The results were the mean of three indepen-
dent experiments and expressed as the percentage increase of PSL arbitrary 
units. Error bars represent SEM. *, P   0.01.
Figure 8. Effects of exogenous ceramides on Fas-mediated apoptosis 
in WR/Fas-SM( ) and WR/Fas-SMS1 cells. Cells were pretreated with the 
indicated concentration of C16- (A) or natural (B) ceramide for 1 h. After 
washing, cells were stimulated with 50 ng/ml CH11 for 6 h and apoptosis was 
analyzed by flow cytometry using PI. Error bars represent SEM.SPHINGOMYELIN/CERAMIDE RAFTS IN APOPTOSIS | Miyaji et al. 256
consensus in type I apoptosis is that FasL, itself a homotrimer,
engages three Fas monomers, leading to the assembly of a tri-
meric Fas receptor. This FasL-induced trimerization has been
suggested to bring together death domains present in the cy-
toplasmic region of each Fas monomer, leading to a DISC
formation. However, it has been reported that soluble FasL
(sFasL) reduced apoptosis by  1,000-fold compared with
membrane-bound FasL (39), and that sFasL or antibodies to
Fas cause cell death more efficiently if polymerized by ad-
sorption on plastic or by molecular cross-linking (40), sug-
gesting that clustering of Fas is important in Fas-mediated
apoptosis. Recently, Fas, as well as TNFR, has been reported
to assemble into trimers in the absence of ligands through a
preligand assembly domain in the extracellular, amino-termi-
nal region of receptors (19, 41). Moreover, Siegel et al.
showed that Fas trimers in the absence of FasL do not recruit
the DISC, implying a lack of apoptotic signaling (19). Thus,
it has been believed that the oligomerization of preassembled
Fas trimers is essential for optimal acute signaling and direct
activation of the caspase cascade through the DISC (18, 21).
However, the molecular basis of Fas clustering is not clear.
It has been reported that Fas ligation triggers transloca-
tion of aSMase from an intracellular compartment onto the
cell surface, where it hydrolyzes SM to ceramide, and that
accumulation of ceramide contributes to transforming small
rafts into larger aggregates for signaling platforms, which trap
and cluster Fas (7, 10, 11, 31, 42). In contrast to the exten-
sive studies of the acid or neutral SMase in cell death, the bi-
ological function of SM synthase has not been elucidated be-
cause of a lack of molecular cloning of its responsible genes.
Recently, we have succeeded in cloning SMS1 (12) and es-
tablished WR/Fas-SM( ) and WR/Fas-SMS1 cells (Fig. 1).
Using this system to investigate the mechanisms of Fas-
mediated apoptosis, we report here that restoration of mem-
brane SM by transfection of SM synthase gene into SM-defi-
cient cells restored Fas-mediated apoptosis (Fig. 2) through
DISC formation (Fig. 4, A and B), activation of caspase-3
(Fig. 3) and caspase-8 (Fig. 4 C), and Fas clustering (Fig. 5).
The equivalent expression of other lipid components in the
plasma membrane, such as ganglioside GM1 and cholesterol
(Fig. 1 C), and equivalent localization of raft fractions in su-
crose density gradients (Fig. 6) argue against other lipid ab-
normalities in SM-deficient cells.
Because lipid rafts promote efficient formation of recep-
tor-associated signaling complexes to produce the biological
outcomes dictated by these complexes (24, 43–45), redistri-
bution of Fas in lipid rafts is one possible mechanism for reg-
ulating the efficiency of Fas signaling. After titration of Tri-
ton X-100 for the isolation of lipid rafts (Fig. S1, available
at http://www.jem.org/cgi/content/full/jem.20041685/
DC1), we examined whether the redistribution of Fas in
lipid rafts is different between WR/Fas-SM( ) and WR/
Fas-SMS1 cells. Although Fas cross-linking enhanced redis-
tribution of Fas into raft fractions in both cells, Fas contents
in raft fractions were greater in WR/Fas-SMS1 than WR/
Fas-SM( ) cells (Fig. 6). These results suggest that mem-
brane SM plays a crucial role for raft partitioning of Fas,
which is one of the important mechanisms in Fas-mediated
apoptosis of these cells.
It has been believed that the trapping and clustering of Fas
may promote the formation of multimers, which ultimately
transmit a strong signal into the cell that induces apoptosis
(18, 21). We examined the efficiency of Fas clustering in
WR/Fas-SM( ) and WR/Fas-SMS1 cells and found that
the aggregation and clustering of Fas in WR/Fas-SMS1 cells
were markedly enhanced after Fas cross-linking compared
with that in WR/Fas-SM( ) cells (Fig. 5), suggesting that
oligomerization of Fas is crucial for optimal apoptosis signal-
ing. Although the exact mechanisms of platform formation
for Fas clustering on the membrane are not clear, it has been
reported that aSMase translocates from an intracellular com-
partment to the extracellular surface of the cell membrane on
Fas stimulation, and that translocation of aSMase to SM-rich
rafts generates ceramide (11, 42). Therefore, using a diacyl-
glycerol kinase assay, we measured ceramide content in raft
fractions of WR/Fas-SM( ) and WR/Fas-SMS1 cells before
and after Fas stimulation. Although ceramide generation in
WR/Fas-SM( ) cells is not increased by Fas cross-linking,
WR/Fas-SMS1 cells showed a 50% increase in ceramide
contents in a raft fraction within 5 min after Fas stimulation
(Fig. 7). Because it has been reported that ceramide displaces
cholesterol from lipid rafts (46) and self-associates within lipid
rafts through hydrogen bonding (47), ceramide may provide
the driving force that results in the coalescence of micro-
scopic rafts into large-membrane macrodomains (48), indicat-
ing that ceramide in rafts serves to form a signaling platform
for Fas clustering (7, 49).
Ceramide has been recognized as an important intracellu-
lar lipid mediator related to a variety of cell functions, includ-
ing cell differentiation and apoptosis (27, 28, 31, 33–37, 50).
It has also been reported that the addition of exogenous natu-
ral  or C16-ceramide enabled soluble FasL to cap and com-
pletely restored the apoptosis in aSMase /  hepatocytes (10,
11, 38). Although exogenous ceramides partially enhanced
Fas-mediated apoptosis, they could neither restore apoptosis
nor enhance Fas multimer formation in WR/Fas-SM( )
cells to the levels in WR/Fas-SMS1 cells (Fig. 8). In this re-
gard, Liu et al. have reported that IL-1  induced the loss of a
resident population of SMs from the SM-rich plasma mem-
brane (i.e., lipid rafts) and the concomitant appearance of
ceramide (51). Therefore, we hypothesize that intact SM-
enriched membrane domains may be essential for local cer-
amide production that compartmentalize lipid rafts to cer-
amide-enriched membrane platforms, leading to Fas capping.
Concerning the molecular ordering of the initial signaling
events of CD95, Algeciras-Schimnich et al. have reported
four stages: (a) ligand-induced formation of CD95 microag-
gregates at the cell surface; (b) recruitment of FADD to form
a DISC; (c) formation of large CD95 surface clusters, which
is positively regulated by DISC-generated caspase-8; and (d)JEM VOL. 202, July 18, 2005 257
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internalization of activated CD95 through an endosomal
pathway (52). We examined caspase-8 activation, ceramide
generation within lipid rafts, redistribution of Fas within lipid
rafts, and Fas multimer formation at very early time points
(Fig. S2, available at http://www.jem.org/cgi/content/full/
jem.20041685/DC1). Caspase-8 activation, ceramide gener-
ation, and Fas redistribution within lipid rafts were observed
within 1 min in WR/Fas-SMS1 but not WR/Fas-SM( )
cells. In contrast, Fas multimer formation was observed in
WR/Fas-SMS1 but not WR/Fas-SM( ) cells at later time
points (after 2 min; Fig. S2). Thus, our findings support a
crucial role for membrane SM in the extrinsic pathway of
Fas-mediated apoptosis through the generation of ceramide
in lipid rafts, which facilitates efficient Fas clustering, DISC
formation, and the early caspase-8 activation leading to the
downstream cascade of caspase-3 activation.
MATERIALS AND METHODS
Cells and cell transfection. Mouse T cell lymphoma WR19L cells
transfected with the cDNA for the human Fas gene (WR19L/Fas; reference
15) were a gift of S. Yonehara (Kyoto University, Kyoto, Japan). We iso-
lated the SM-defective WR/Fas-SM( ) cells and the SM-containing WR/
Fas-SM( ) cells from the original WR19L/Fas cells by limiting dilution.
SMS1, subcloned into the pLIB expression vector, was transfected into the
WR/Fas-SM( ) cells in VSV-G retroviral particles. These cells were desig-
nated WR/Fas-SMS1 cells (12).
Antibodies and reagents. Anti-Fas (CH11, mouse IgM) and anti-FADD
(1F7, mouse IgG1) were purchased from MBL International Corporation.
FITC-conjugated anti–mouse IgM, anti–mouse IgG2a, anti–human Fas
(DX2), and anti–caspase-3/CPP32 pAb were purchased from BD Bio-
sciences. Anti-Fas death domain (3D5) and anti–caspase-8 (1G12) antibod-
ies were purchased from Qbiogene. Lysenin, FITC-conjugated CTx, per-
oxidase-conjugated CTx, and methyl- -cyclodextrin were purchased from
Sigma-Aldrich. Rabbit anti–mouse IgG mAb was purchased from Cappel.
Ac-DEVD-CHO and Ac-IETD-CHO were purchased from Peptide Insti-
tute. RNase and saponin were purchased from Nacalai Tesque. The cell vi-
ability assay kit using WST-8 (2-(2-methoxy-4-nitrophenyl)-3-(4-nitro-
phenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium) was purchased from Wako
Co. Ltd. L-[14C]serine and  -[32P]ATP were purchased from GE Health-
care. Rabbit anti–mouse IgM (  chain specific) antibody was purchased
from Zymed Laboratories. The ECL immunodetection system and horse-
radish peroxidase–conjugated goat anti–mouse or anti–rabbit IgG mAb
were obtained from GE Healthcare.
FACS analysis. DNA fragmentation was quantified by analyzing cell cycle
and total DNA content to measure cell death by apoptosis. In brief, cells were
treated with CH11 at the indicated concentration and incubated for the indi-
cated time shown in the figures. After harvesting, cells were resuspended in
permeabilization solution (0.5% paraformaldehyde and 0.5% saponin) and
treated with 50  g/ml RNase A for 30 min at room temperature, and pro-
pidium iodide (PI; Molecular Probes) was added to a final concentration of
20  g/ml. After 20 min, the fluorescence of the PI-stained DNA was quanti-
tated on a per cell basis using a FACSCalibur (BD Biosciences), and cells with
subdiploid content were considered to be apoptotic cells.
To detect SM localized at the outer leaflet of the plasma membrane,
cells were stained on ice for 30 min with nontoxic lysenin–MBP (16), incu-
bated for 30 min with FITC-conjugated anti–mouse IgG (Sigma-Aldrich),
and analyzed with a FACSCalibur. Surface expression of ganglioside GM1
and cholesterol was analyzed using FITC-conjugated CTx) or fPEG-cho-
lesterol (17), respectively. Data were analyzed using CellQuest software
(Becton Dickinson).
To assess   m, healthy or dying cells were incubated for 15 min at
37 C in buffer containing 40 nM 3,3 -dihexyloxacarbocyanine iodide
(DiOC6(3); Molecular Probes) before the addition of 5  g/ml PI. After
compensation to exclude nonviable cells, fluorescence was recorded at 525
nM (FL-1) for DiOC6(3) and 600 nM (FL-3) for PI on a FACScan (26).
Confocal microscopy. To assess Fas capping, cells were stained for 20 min
with 50 ng/ml of CH11 at 4 C, and capping was induced by warming cells to
37 C in a water bath with mild agitation. Cells were harvested at the indi-
cated times shown in the figures and fixed with 4% paraformaldehyde for 10
min at 22 C. Fixed cells were washed twice and mounted in FITC-conju-
gated secondary antibody. Fluorescence was detected with a confocal micro-
scope (LSM-5 Pascal; Carl Zeiss MicroImaging, Inc.) equipped with a SPOT
digital camera. Large clusters of Fas were defined as cells in which the fluores-
cence condenses onto  25% of the cell surface, whereas fluorescence was ho-
mogeneously distributed on the membrane of resting cells.
For visualization of SM localized at the outer leaflet of the plasma
membrane, cells were allowed to settle onto slides coated with poly–L-
lysine, fixed in 4% formaldehyde, stained with lysenin–MBP at 4 C for 45
min, and treated with anti-MBP.
Cell labeling and lipid separation. The method for detection of SM
synthesis is described elsewhere (28). In brief, cells were reseeded at 5   105
cells/ml in RPMI 1640 with 2% FBS and L-[14C]serine (specific activity,
155 mCi/mmol) and incubated at 37 C in 5% CO2 for 36 h. The cell lipids
were extracted by the method of Bligh and Dyer (53), applied on silica gel
TLC plate (Whatman), and developed with solvent containing methyl ace-
tate/propanol/chloroform/methanol/0.25% KCl (25:25:25:10:9). The ra-
dioactive spots were visualized and quantified using an image analyzer (BAS
2000; Fuji Photo Film).
Immunoprecipitation, Western blotting, and immunoblotting.
Cells were solubilized with lysis buffer containing 50 mM Tris-HCl, pH 7.6,
1% Brij 97, 300 mM NaCl, 5 mM EDTA, 10  g/ml leupeptin, 10  g/ml
aprotinin, 1 mM PMSF, and 1 mM sodium orthovanadate with gentle rock-
ing for 30 min at 4 C. Immunoprecipitated proteins were eluted by boiling in
SDS-containing sample buffer and fractionated by SDS-PAGE (8–12% poly-
acrylamide gels; reference 54). Proteins were electrophoretically transferred
to polyvinylidene difluoride (Immobilon-P) membranes (Sigma-Aldrich).
Peroxidase-conjugated secondary antibodies (GE Healthcare) were used at a
1:1,000 dilution, and immunoreactive bands were visualized using ECL.
Densitometry of the protein bands was performed using National Institutes of
Health image software (55). Quantitation of Fas in raft fractions was corrected
to the amount of lck.
The aggregated form of Fas was detected by the method of Kamitani et
al. (22). In brief, cell pellets were snap frozen to prevent protein degrada-
tion. Frozen pellets were treated at 45 C for 1 h in 300 ml of 2% treating
solution containing 5%  -mercaptoethanol. DNA in the samples were
sheared with a 25-gauge needle, and solubilized samples were loaded on
12% SDS-PAGE. Aggregated Fas was detected by 3D5, a mouse mAb
(IgG1) specific for the intracellular death domain of human Fas (Qbiogene).
Caspase activity assay. Activities of caspase-3 and -8 were determined
using a colorimetric assay kit (MBL International Corporation) according to
the manufacturer’s protocol. Apoptosis inhibition was assayed in cells stimu-
lated for 6 h with 50 ng/ml CH11 in the presence of the indicated doses of
Ac-DEVD-CHO or Ac-IETD-CHO shown in the figures.
Isolation of a raft fraction in equilibrium density gradients. Raft
fractions were prepared as described by Rodgers and Rose (56) with minor
modifications (8). In brief, 108 cells were lysed with 1 ml MS-buffered sa-
line (MBS; 25 mM MES, pH 6.5, and 150 mM NaCl) containing 1% Tri-
ton X-100, 10  g/ml aprotinin, 10  g/ml leupeptin, 1 mM PMSF, 1 mM
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with 20 strokes of a Dounce homogenizer (Iwaki Glass Co.), gently mixed
with an equal volume of 80% sucrose (wt/vol) in MBS, and placed in the
bottom of a 14   95 mm clear centrifuge tube (model 344060; Beckman
Coulter). The sample was then overlaid with 6.5 ml of 30% sucrose and 3.5
ml of 5% sucrose in MBS and centrifuged at 200,000 g in a rotor (model
SW40Ti; Beckman Coulter) at 4 C for 16 h. After centrifugation, 12 1-ml
fractions (excluding the pellet) were collected from the top of the gradient.
Ceramide measurement. Lipids were extracted from cell lysates by the
method of Bligh and Dyer (53), and ceramide mass measurement using
Escherichia coli diacylglycerol kinase, which phosphorylates ceramide to cer-
amide-1-phosphate, was performed as described previously (50). The sol-
vent system to separate ceramide-1-phosphate and phosphatidic acid on
TLC plates consists of chloroform/acetone/methanol/acetic acid/H2O (10:
4:3:2:1). Radioactivity within spots of ceramide-1-phosphate was estimated
with an image analyzer system (BASE III; Fuiji) and expressed as PSL arbi-
trary units (54), and ceramide levels were corrected for phospholipid phos-
phate as described elsewhere (57).
Statistical analysis. Statistical significance was evaluated by unpaired t
tests and by analysis of variance as applicable; P   0.01 was considered sta-
tistically significant.
Online supplemental material. Fig. S1 shows concentration of Triton
X-100 for lipid raft separation. Fig. S2 shows early timecourse of caspase-8
activity, ceramide generation in lipid rafts, Fas redistribution into lipid rafts,
and Fas multimer formation. Online supplemental material is available at
http://www.jem.org/cgi/content/full/jem.20041685/DC1.
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